Featured Articles

  1. The Past And Future Of Managing Raw Material And Process Risks In Biomanufacturing 9/18/2018

    How far have we come in raw material supply management, and what still needs accomplished to ensure the delivery of safe and effective drugs?

  2. How A New Factory-In-A-Box Is Helping Scale Up Manufacturing Of Viral Vector Based Therapies To Reach More Patients 8/31/2018

    Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.

  3. FUJIFILM Diosynth Biotechnologies Drives Flexibility And Efficiency In Their Biomanufacturing Platform Using Integrated Automation 8/30/2018

    Through a successful implementation, FUJIFILM Diosynth was able to not only recognize the benefits that an integrated automation platform offers but also the importance of working with an experienced partner.

  4. Protein Analysis With Size Exclusion Chromatography (SEC) 2/20/2018

    This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.

  5. Buffer Management Solutions For Large-Scale Biomanufacturing 2/1/2018

    How outsourcing and technologies such as in-line conditioning and in-line dilution can help prevent resource constraints, save time, and reduce manufacturing footprint and cost in buffer preparation.

  6. Expand Capacity In Buffer Management 2/1/2018

    Biomanufacturing requires large volumes of buffers, and preparation of these liquids can quickly become a bottleneck. Here, two options that can help intensify your large-scale buffer management are presented.

  7. Standardization And Flexibility In Aseptic Filling

    Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?

  8. Research And Industry Join Forces As Modalities Merge

    How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.

  9. Staying Flexible In Biomanufacturing

    The concept of optionality is key to staying flexible in biomanufacturing by keeping your options open and having multiple pathways to take while navigating through this highly uncertain environment. 

  10. How Biogen Integrated PAT With End-To-End Supply Chain Transparency

    To drive dependable critical process control requirements, Biogen explored novel strategies to increase process and raw material control and optimize communication of data throughout the supply chain.